Fundamental Analysis of Laird Superfood (LSF)

Laird Superfood, Inc. creates award-winning, plant-based superfood products that are both delicious and functional. The Company’s products are designed to enhance your daily ritual and keep consumers fueled naturally throughout the day. The Company was co-founded in 2015 by the world’s most prolific big-wave surfer, Laird Hamilton. Laird Superfood’s offerings are environmentally conscientious, responsibly tested and made with real ingredients. Shop all products online at and join the Laird Superfood community on social media for the latest news and daily doses of inspiration.

Laird Superfood recently released its financial results for the fourth quarter and full year of 2023, showcasing positive developments for the company. Here’s a breakdown of the key takeaways:

Strong Q4 Performance

  • Positive Net Income: For the first time in the company’s history, Laird Superfood achieved positive net income of $0.1 million in Q4 2023. This marks a significant turnaround compared to the net loss of $2.7 million in the previous quarter.
  • Improved Gross Margin: Gross margin rose significantly to 40.4% in Q4 2023, compared to 31.0% in Q3 2023 and a negative margin in the prior year. This substantial improvement is attributed to the shift towards a variable cost co-manufacturing model.
  • Positive Cash Flow: The company achieved positive cash flow of $0.3 million in Q4 2023, indicating a shift from cash usage in previous quarters.

Full Year 2023 Highlights

  • Reduced Net Loss: While still a net loss of $10.2 million, this represents a significant decrease compared to the $40.3 million loss in 2022.
  • Improved Gross Margin: Similar to Q4, the company’s overall gross margin for 2023 reached 30.1%, compared to just 14.5% in the previous year.
  • Reduced Cash Burn: Cash used in operating activities decreased in 2023 compared to 2022, reflecting the efficiency gains from the co-manufacturing model.

Looking Ahead

  • Growth Projection: Laird Superfood anticipates net sales to grow between 10% and 15% in 2024, reaching a range of $38 million to $40 million.
  • Continued Margin Expansion: The company expects gross margin to further expand to 37-40% in 2024, excluding one-time charges.

Financial Strength

  • Debt-Free: As of December 31, 2023, Laird Superfood boasts a debt-free balance sheet with $7.7 million in cash and cash equivalents.
  • Improved Cash Flow: The company projects sufficient cash to fund operations into 2026, eliminating the need for the “going concern” clause previously included in financial reports.

Laird superfood stock chart

Laird Superfood’s recent financial report paints a picture of a company on the upswing. While challenges remain, LSF appears to be taking positive strides towards profitability and market share growth. Let’s delve into a SWOT analysis to understand their current position:


  • Improved Financials: Positive net income and operating cash flow for the first time signifies a significant turnaround. Gross margin expansion indicates a more efficient business model.
  • Strategic Distribution Channels: Growth in both wholesale and e-commerce channels demonstrates a well-rounded approach. Strong club and grocery store presence alongside a thriving DTC platform offer a diverse customer base.
  • Brand Recognition: Co-founder Laird Hamilton’s association and focus on plant-based, functional superfoods create a unique brand identity that resonates with health-conscious consumers.


  • Reliance on E-commerce: Though showing signs of recovery, LSF still faces challenges in the e-commerce space, particularly with declining Amazon sales. Dependence on a single platform can be risky.
  • Limited Product Portfolio: While LSF offers a variety of superfood products, diversification into new categories could open up additional revenue streams and attract a wider audience.
  • Recent Operational Changes: The shift to a co-manufacturing model, while improving efficiency, might require close monitoring to ensure consistent product quality and brand image.


  • Market Growth: The superfood market is projected to continue expanding, presenting LSF with a chance to capitalize on the increasing demand for health and wellness products.
  • Global Expansion: Exploring international markets, particularly in Asia and Latin America, could be a significant growth driver.
  • Strategic Partnerships: Collaborations with complementary brands in the health and wellness industry could leverage each other’s strengths and expand market reach.


  • Competition: The superfood market is becoming increasingly crowded, with established players and new entrants vying for market share. LSF needs to maintain its competitive edge through innovation and effective marketing.
  • Regulation: The food and beverage industry is subject to evolving regulations. LSF needs to stay compliant with any changes to ensure product safety and avoid disruptions.
  • Supply Chain Disruptions: Reliance on a complex supply chain can be vulnerable to unforeseen events like natural disasters or geopolitical issues. LSF needs to build resilience into its sourcing and production processes.


Laird Superfood’s recent financial performance indicates a positive trajectory. By capitalizing on its strengths in brand recognition, diverse distribution channels, and a focus on functional superfoods, LSF can solidify its position in the growing market. However, addressing weaknesses in product diversification and potential over-reliance on e-commerce channels is crucial. Navigating the competitive landscape, regulatory changes, and potential supply chain disruptions will require strategic planning and proactive measures.

Disclaimer: This analysis is for informational purposes only and should not be considered financial advice.

Additional Resources

Related Articles:

Fundamental Analysis of Discover Financial Services (DFS)

Fundamental Analysis of Spirit AeroSystems (SPR)

Fundamental Analysis of Ocugen Inc (OCGN)

Fundamental Analysis of Mobileye (MBLY)

Fundamental Analysis of ClearOne Inc (CLRO)

Fundamental Analysis of ANI Pharmaceuticals (ANIP)

Leave A Reply

Your email address will not be published. Required fields are marked *